These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1246206)

  • 1. Effect of contraceptive steroids on arginine- stimulated glucagon and insulin secretion in women. II. Carbohydrate and lipid physiology in insulin-dependent diabetics.
    Beck P; Arnett DM; Alsever RN; Eaton RP
    Metabolism; 1976 Jan; 25(1):23-31. PubMed ID: 1246206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology.
    Beck P; Eaton RP; Arnett DM; Alsever RN
    Metabolism; 1975 Sep; 24(9):1055-65. PubMed ID: 1152675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate.
    Beck P; Zimmerman DE; Eaton RP
    Metabolism; 1977 Nov; 26(11):1193-8. PubMed ID: 909395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid, carbohydrate, and androgen metabolism in women using a triphasic oral contraceptive containing norethindrone for one year.
    Rabe T; Runnebaum B; Kohlmeyer M; Weicker H
    Int J Fertil; 1986; 31 SU [UPDATE]():46-52. PubMed ID: 2899559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma high-density-lipoprotein cholesterol levels during long-term use of an oral contraceptive in Nigerian women.
    Taylor GO; Agbedana EO; Ojo OA
    Br J Obstet Gynaecol; 1982 Nov; 89(11):944-7. PubMed ID: 7171504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of arterial smooth muscle cell mitogens in the blood of oral contraceptive users.
    Bagdade JD; Subbaiah PV; Hintz RL; Wilson DM
    Atherosclerosis; 1985 Aug; 56(2):149-55. PubMed ID: 2934071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D- hydroxybutyrate and triglycerides.
    Lunell NO; Persson B; Ohqvist G
    Acta Obstet Gynecol Scand; 1973; 52(1):23-4. PubMed ID: 4688539
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids.
    Larsson-Cohn U; Berlin R; Vikrot O
    Acta Endocrinol (Copenh); 1970 Apr; 63(4):717-35. PubMed ID: 4194179
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of norethindrone on carbohydrate and lipid metabolism.
    Spellacy WN; Buhi WC; Birk SA
    Obstet Gynecol; 1975 Nov; 46(5):560-3. PubMed ID: 1196559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
    Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC
    Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.